Skip to search.
 FTSE 100 Up 1.63%

Kite Pharma, Inc. (KITE)

-NasdaqGS
47.28 Down 3.82(7.48%) 16:26 - Nasdaq Real Time Price
Prev Close:51.10
Open:49.61
Bid:47.48 x 200
Ask:47.56 x 500
1y Target Est:75.00
Beta:N/A
Earnings Date:27 Feb - 3 Mar (Est.)
Day's Range:47.00 - 50.99
52wk Range:38.41 - 73.85
Volume:859,295
Avg Vol (3m):1,168,160
Market Cap:2.36b
P/E (ttm):N/A
EPS (ttm):-4.60
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
KITEDown 7.48%2.36b
PFEDown 2.79%186.18b
CELGDown 5.74%85.78b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):115.06
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-5.56
Quarterly EPS Est (Dec-16) :-1.78
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Kite Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel cancer immunotherapy products. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback